256 related articles for article (PubMed ID: 10430971)
1. Familial clustering of end-stage renal disease in blacks with HIV-associated nephropathy.
Freedman BI; Soucie JM; Stone SM; Pegram S
Am J Kidney Dis; 1999 Aug; 34(2):254-8. PubMed ID: 10430971
[TBL] [Abstract][Full Text] [Related]
2. Familial clustering of end-stage renal disease in blacks with lupus nephritis.
Freedman BI; Wilson CH; Spray BJ; Tuttle AB; Olorenshaw IM; Kammer GM
Am J Kidney Dis; 1997 May; 29(5):729-32. PubMed ID: 9159307
[TBL] [Abstract][Full Text] [Related]
3. Human immunodeficiency virus/acquired immunodeficiency syndrome-associated nephropathy at end-stage renal disease in the United States: patient characteristics and survival in the pre highly active antiretroviral therapy era.
Abbott KC; Hypolite I; Welch PG; Agodoa LY
J Nephrol; 2001; 14(5):377-83. PubMed ID: 11730270
[TBL] [Abstract][Full Text] [Related]
4. Racial variation in autosomal dominant polycystic kidney disease.
Freedman BI; Soucie JM; Chapman A; Krisher J; McClellan WM
Am J Kidney Dis; 2000 Jan; 35(1):35-9. PubMed ID: 10620541
[TBL] [Abstract][Full Text] [Related]
5. Familial predisposition to nephropathy in African-Americans with non-insulin-dependent diabetes mellitus.
Freedman BI; Tuttle AB; Spray BJ
Am J Kidney Dis; 1995 May; 25(5):710-3. PubMed ID: 7747724
[TBL] [Abstract][Full Text] [Related]
6. Family history of end-stage renal disease does not predict dialytic survival.
Freedman BI; Soucie JM; Kenderes B; Krisher J; Garrett LE; Caruana RJ; McClellan WM
Am J Kidney Dis; 2001 Sep; 38(3):547-52. PubMed ID: 11532687
[TBL] [Abstract][Full Text] [Related]
7. HIV-associated nephropathy.
Winston J; Klotman PE
Mt Sinai J Med; 1998 Jan; 65(1):27-32. PubMed ID: 9458681
[TBL] [Abstract][Full Text] [Related]
8. Racial differences in end-stage renal disease rates in HIV infection versus diabetes.
Choi AI; Rodriguez RA; Bacchetti P; Bertenthal D; Volberding PA; O'Hare AM
J Am Soc Nephrol; 2007 Nov; 18(11):2968-74. PubMed ID: 17942954
[TBL] [Abstract][Full Text] [Related]
9. End-stage renal disease among HIV-infected adults in North America.
Abraham AG; Althoff KN; Jing Y; Estrella MM; Kitahata MM; Wester CW; Bosch RJ; Crane H; Eron J; Gill MJ; Horberg MA; Justice AC; Klein M; Mayor AM; Moore RD; Palella FJ; Parikh CR; Silverberg MJ; Golub ET; Jacobson LP; Napravnik S; Lucas GM;
Clin Infect Dis; 2015 Mar; 60(6):941-9. PubMed ID: 25409471
[TBL] [Abstract][Full Text] [Related]
10. Trends in the outcomes of end-stage renal disease secondary to human immunodeficiency virus-associated nephropathy.
Razzak Chaudhary S; Workeneh BT; Montez-Rath ME; Zolopa AR; Klotman PE; Winkelmayer WC
Nephrol Dial Transplant; 2015 Oct; 30(10):1734-40. PubMed ID: 26175146
[TBL] [Abstract][Full Text] [Related]
11. Predictors of renal outcome in HIV-associated nephropathy.
Post FA; Campbell LJ; Hamzah L; Collins L; Jones R; Siwani R; Johnson L; Fisher M; Holt SG; Bhagani S; Frankel AH; Wilkins E; Ainsworth JG; Larbalestier N; Macallan DC; Banerjee D; Baily G; Thuraisingham RC; Donohoe P; Hendry BM; Hilton RM; Edwards SG; Hangartner R; Howie AJ; Connolly JO; Easterbrook PJ
Clin Infect Dis; 2008 Apr; 46(8):1282-9. PubMed ID: 18444868
[TBL] [Abstract][Full Text] [Related]
12. Higher protein intake is associated with increased risk for incident end-stage renal disease among blacks with diabetes in the Southern Community Cohort Study.
Malhotra R; Cavanaugh KL; Blot WJ; Ikizler TA; Lipworth L; Kabagambe EK
Nutr Metab Cardiovasc Dis; 2016 Dec; 26(12):1079-1087. PubMed ID: 27562875
[TBL] [Abstract][Full Text] [Related]
13. Familial clustering of end-stage renal disease in Mississippi.
Butkus DE
J Miss State Med Assoc; 2002 Mar; 43(3):71-7. PubMed ID: 11944578
[TBL] [Abstract][Full Text] [Related]
14. Gene-gene and gene-environment interactions in HIV-associated nephropathy: A focus on the MYH9 nephropathy susceptibility gene.
Núñez M; Saran AM; Freedman BI
Adv Chronic Kidney Dis; 2010 Jan; 17(1):44-51. PubMed ID: 20005488
[TBL] [Abstract][Full Text] [Related]
15. Population-based screening for family history of end-stage renal disease among incident dialysis patients.
Freedman BI; Volkova NV; Satko SG; Krisher J; Jurkovitz C; Soucie JM; McClellan WM
Am J Nephrol; 2005; 25(6):529-35. PubMed ID: 16179780
[TBL] [Abstract][Full Text] [Related]
16. The familial risk of end-stage renal disease in African Americans.
Freedman BI; Spray BJ; Tuttle AB; Buckalew VM
Am J Kidney Dis; 1993 Apr; 21(4):387-93. PubMed ID: 8465818
[TBL] [Abstract][Full Text] [Related]
17. Intermediate outcomes by race and ethnicity in peritoneal dialysis patients: results from the 1997 ESRD Core Indicators Project. National ESRD Core Indicators Workgroup.
Rocco MV; Frankenfield DL; Frederick PR; Pugh J; McClellan WM; Owen WF
Perit Dial Int; 2000; 20(3):328-35. PubMed ID: 10898051
[TBL] [Abstract][Full Text] [Related]
18. Kidney disease in the first-degree relatives of African-Americans with hypertensive end-stage renal disease.
Bergman S; Key BO; Kirk KA; Warnock DG; Rostant SG
Am J Kidney Dis; 1996 Mar; 27(3):341-6. PubMed ID: 8604702
[TBL] [Abstract][Full Text] [Related]
19. The human immunodeficiency virus (HIV) epidemic and HIV-associated nephropathy.
Winston JA; Burns GC; Klotman PE
Semin Nephrol; 1998 Jul; 18(4):373-7. PubMed ID: 9692350
[TBL] [Abstract][Full Text] [Related]
20. Pharmacotherapy and treatment options for HIV-associated nephropathy.
Menez S; Hanouneh M; McMahon BA; Fine DM; Atta MG
Expert Opin Pharmacother; 2018 Jan; 19(1):39-48. PubMed ID: 29224373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
